Stock Information
Definium Therapeutics Inc (DFTX)
Ticker Symbol: DFTX
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $4,154.35 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.43
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -85.23%
Latest News
-
Definium Therapeutics Highlights Phase III DT120 Gains in Anxiety and Depression
Thu, Sep 24, 2026 6:02 AM
-
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Mon, Sep 21, 2026 3:01 PM
-
Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching
Sun, Sep 20, 2026 4:28 PM
-
Definium Therapeutics’ DT120 Hits Phase III Goals in Anxiety Study
Sat, Sep 19, 2026 11:02 PM
Key Financials
Financial data not available
